<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font32 { font-size : 32; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font24 { font-size : 24; } .font25 { font-size : 25; } .font26 { font-size : 26; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font32">patients </span>
   <span class="font30">antiviral </span>
   <span class="font26">therapy </span>
   <span class="font25">treatment </span>
   <span class="font25">HBV </span>
   <span class="font24">hepatitis </span>
   <span class="font22">studies </span>
   <span class="font22">{border-style </span>
   <span class="font21">analysis </span>
   <span class="font21">study </span>
   <span class="font20">():–. </span>
   <span class="font20">px;} </span>
   <span class="font20">trials </span>
   <span class="font20">#ffffff;} </span>
   <span class="font20">Hepatitis </span>
   <span class="font20">remission </span>
   <span class="font19">HBeAg </span>
   <span class="font19">Medicine </span>
   <span class="font19">renal </span>
   <span class="font19">CI: </span>
   <span class="font19">proteinuria </span>
   <span class="font18">Fig </span>
   <span class="font18">data </span>
   <span class="font18">effects </span>
   <span class="font18">included </span>
   <span class="font18">virus-associated </span>
   <span class="font17">Health </span>
   <span class="font17">IFNs </span>
   <span class="font17">clinical </span>
   <span class="font17">(OR </span>
   <span class="font17">Sciences </span>
   <span class="font17">efficacy </span>
   <span class="font17">pediatric </span>
   <span class="font16">Clinical </span>
   <span class="font16">HBV-GN </span>
   <span class="font16">bias </span>
   <span class="font16">performed </span>
   <span class="font16">study[] </span>
   <span class="font16">adult </span>
   <span class="font16">al[] </span>
   <span class="font16">group </span>
   <span class="font16">heterogeneity </span>
   <span class="font16">patients. </span>
   <span class="font16">showed </span>
   <span class="font16">test </span>
   <span class="font16">total </span>
   <span class="font15">Antiviral </span>
   <span class="font15">clearance </span>
   <span class="font15">eGFR </span>
   <span class="font15">effect </span>
   <span class="font15">follow-up </span>
   <span class="font15">rate </span>
   <span class="font15">results </span>
   <span class="font15">review </span>
   <span class="font15">type </span>
   <span class="font15">virus </span>
   <span class="font14">analyses </span>
   <span class="font14">anti-viral </span>
   <span class="font14">chronic </span>
   <span class="font14">did </span>
   <span class="font14">different </span>
   <span class="font14">drug </span>
   <span class="font14">model </span>
   <span class="font14">nephropathy </span>
   <span class="font14">px; </span>
   <span class="font14">sensitivity </span>
   <span class="font14">significant </span>
   <span class="font14">using </span>
   <span class="font14">{font-family </span>
   <span class="font14">Cochrane </span>
   <span class="font14">DNA </span>
   <span class="font14">However, </span>
   <span class="font14">Subgroup </span>
   <span class="font14">age </span>
   <span class="font14">drugs </span>
   <span class="font14">duration </span>
   <span class="font14">effective </span>
   <span class="font14">evaluated </span>
   <span class="font14">font-size </span>
   <span class="font14">odds </span>
   <span class="font14">outcome </span>
   <span class="font14">serum </span>
   <span class="font14">subgroup </span>
   <span class="font14">used </span>
   <span class="font13">(Fig </span>
   <span class="font13">Biology </span>
   <span class="font13">CCT </span>
   <span class="font13">Chinese </span>
   <span class="font13">Click </span>
   <span class="font13">LINK </span>
   <span class="font13">NAs </span>
   <span class="font13">NAs. </span>
   <span class="font13">OR: </span>
   <span class="font13">additional </span>
   <span class="font13">adverse </span>
   <span class="font13">al.[] </span>
   <span class="font13">complete </span>
   <span class="font13">control </span>
   <span class="font13">controlled </span>
   <span class="font13">double; </span>
   <span class="font13">file. </span>
   <span class="font13">glomerular </span>
   <span class="font13">glomerulonephritis </span>
   <span class="font13">heterogeneity. </span>
   <span class="font13">meta-analysis </span>
   <span class="font13">patients, </span>
   <span class="font13">remission. </span>
   <span class="font13">(/, </span>
   <span class="font13">(TIF) </span>
   <span class="font13">.−.). </span>
   <span class="font13">China </span>
   <span class="font13">Therapy </span>
   <span class="font13">Treatment </span>
   <span class="font13">articles </span>
   <span class="font13">border-color </span>
   <span class="font13">border-width </span>
   <span class="font13">evaluate </span>
   <span class="font13">fixed-effect </span>
   <span class="font13">groups </span>
   <span class="font13">including </span>
   <span class="font13">infection </span>
   <span class="font13">pathogens </span>
   <span class="font13">pathological </span>
   <span class="font13">random </span>
   <span class="font13">risk </span>
   <span class="font13">safety </span>
   <span class="font13">solid; </span>
   <span class="font13">terms </span>
   <span class="font13">trial </span>
   <span class="font13">trials. </span>
   <span class="font13">viral </span>
   <span class="font13">{font-style </span>
   <span class="font13">{font-weight </span>
   <span class="font12">.%), </span>
   <span class="font12">.±. </span>
   <span class="font12">.−.) </span>
   <span class="font12">.−., </span>
   <span class="font12">American </span>
   <span class="font12">CR: </span>
   <span class="font12">Controlled </span>
   <span class="font12">Gastroenterology. </span>
   <span class="font12">IFNs, </span>
   <span class="font12">International </span>
   <span class="font12">Kidney </span>
   <span class="font12">Nephrology. </span>
   <span class="font12">PRISMA </span>
   <span class="font12">Randomized </span>
   <span class="font12">Research </span>
   <span class="font12">Study </span>
   <span class="font12">Sun </span>
   <span class="font12">Sun’s </span>
   <span class="font12">Trials </span>
   <span class="font12">Viral </span>
   <span class="font12">antigen </span>
   <span class="font12">article </span>
   <span class="font12">based </span>
   <span class="font12">bold </span>
   <span class="font12">cohort </span>
   <span class="font12">courier; </span>
   <span class="font12">data. </span>
   <span class="font12">differences </span>
   <span class="font12">eligible </span>
   <span class="font12">em; </span>
   <span class="font12">events </span>
   <span class="font12">filtration </span>
   <span class="font12">focused </span>
   <span class="font12">glomerulonephritis. </span>
   <span class="font12">glomerulonephritis: </span>
   <span class="font12">higher </span>
   <span class="font12">immune </span>
   <span class="font12">mainly </span>
   <span class="font12">membranous </span>
   <span class="font12">mentioned </span>
   <span class="font12">original </span>
   <span class="font12">pt;} </span>
   <span class="font12">randomized </span>
   <span class="font12">ratio; </span>
   <span class="font12">regarding </span>
   <span class="font12">related </span>
   <span class="font12">replication </span>
   <span class="font12">secondary </span>
   <span class="font12">sensitive </span>
   <span class="font12">significantly </span>
   <span class="font12">studies, </span>
   <span class="font12">symptoms </span>
   <span class="font12">systematic </span>
   <span class="font12">treated </span>
   <span class="font12">trials, </span>
  </p>
 </body>
</html>
